Nura
Founded Year
2003Stage
Acquired | AcquiredTotal Raised
$16.7MValuation
$0000Missing: Nura's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Nura's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Nura
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Nura is included in 1 Expert Collection, including Conference Exhibitors.
Conference Exhibitors
6,062 items
Companies that will be exhibiting at CES 2018
Nura Patents
Nura has filed 13 patents.
The 3 most popular patent topics include:
- Audio engineering
- Audio equipment manufacturers
- Acoustics
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
7/10/2018 | 7/7/2020 | Audio engineering, Acoustics, Loudspeakers, Hearing, Audio equipment manufacturers | Grant |
Application Date | 7/10/2018 |
|---|---|
Grant Date | 7/7/2020 |
Title | |
Related Topics | Audio engineering, Acoustics, Loudspeakers, Hearing, Audio equipment manufacturers |
Status | Grant |
Latest Nura News
Jun 28, 2022
Nura — the Australian company behind the innovative Nuraphone headphones, which measure your ears’ unique architecture in order to customize the sound — is working
Nura Frequently Asked Questions (FAQ)
When was Nura founded?
Nura was founded in 2003.
Where is Nura's headquarters?
Nura's headquarters is located at 1420 Fifth Avenue, Seattle.
What is Nura's latest funding round?
Nura's latest funding round is Acquired.
How much did Nura raise?
Nura raised a total of $16.7M.
Who are the investors of Nura?
Investors of Nura include Omeros, Linkagene, Cercano Management, Novartis Venture Funds, Venture Associates and 19 more.
Who are Nura's competitors?
Competitors of Nura include Cerecin, Checkpoint Surgical, Oxurion, Orexigen Therapeutics, CureTech and 12 more.
Compare Nura to Competitors
Quantum Immunologics, Inc. ("QI") is a research-driven biotechnology company that is working on discoveries in immunotherapy science. QI is dedicated to the research, development and production of technologies that focus on the treatments and diagnoses of cancer and other diseases related to the immune system. Leveraging an expansive pipeline of biopharmaceutical innovations, QI remains committed to advancing medicine with the ultimate goal of dramatically improving lives.
nnBio3 Research s.r.l. is a private biopharmaceutical company based in Milan, Italy, with a USA subsidiary, Bio3 Research Inc., based in Hayward/CA. Bio3 Research develops new compounds up to IND stage with potential in cardiovascular field. The company is focused in the area of cardiovascular disorders related to HMGB1 (High Mobility Group Box 1) over-expression.
Kaperio is a biopharmaceutical company focused on cardiovascular disease.
Janus Pharmaceuticals Inc. (Janus) is a specialty pharmaceutical company identifying, acquiring and aggressively developing topical prescription products for treatment of skin infections. Determined to be the "Dermal Alternative", Janus has already established a strong intellectual property portfolio for topical anti-infective compounds that would be rapidly commercialized through fast regulatory pathways. Led by an accomplished management team and board located in the US and Japan, Janus has trans-Pacific network and resources in the biopharmaceutical industry.
Checkpoint Surgical provides surgeons with neurodevices to preserve nerves and evaluate nerve and muscle excitability in surgical procedures for better patient outcomes. Checkpoint Surgical launched the CHECKPOINT Stimulator/Locator as its flagship product in a line of neuromuscular surgical devices.
Hunter-Fleming is a biopharmaceutical company developing new medicines to treat neurological and cardiovascular disorders. The company focus is on unmet patient needs in dementias such as Alzheimer's disease, as well as other important conditions such as neuropathic pain, head and spinal cord injuries and myocardial infarction.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.